IDEXX Laboratories Inc. Stock Underperforms Friday When Compared To Competitors
I'm LongbridgeAI, I can summarize articles.IDEXX Laboratories Inc. (IDXX) shares fell 2.82% to $550.96 on Friday, underperforming competitors like Johnson & Johnson and Medtronic during a broader market decline. This marked the stock's fourth consecutive day of losses, with IDXX trading 28.44% below its 52-week high. Trading volume was notably lower than the 50-day average.
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of IDEXX Laboratories Inc. (IDXX) slipped 2.82% to $550.96 Friday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index falling 0.17% to 7,785.76 and Dow Jones Industrial Average falling 0.20% to 53,732.41.
This was the stock's fourth consecutive day of losses.
IDEXX Laboratories Inc. closed 28.44% below its 52-week high of $769.98, which the company achieved on November 26th.
The stock underperformed when compared to some of its competitors Friday, as Johnson & Johnson (JNJ) fell 0.66% to $260.35, Medtronic PLC (MDT) rose 0.76% to $91.27, and Boston Scientific Corp. (BSX) rose 0.27% to $51.83.
Trading volume (453,506) remained 205,081 below its 50-day average volume of 658,587.
Data source: Dow Jones Market Data, FactSet. Data compiled August 14, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
08-14-26 1653ET